BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.13+0.12 (+1.50%)
Close on Nov 17, 2026Market cap $3.26BP/E –Yield –
BGM total assets
Total assets on the balance sheet at the end of each period.
BGM's total assets was $433.81M at Sep 30, 2025. For fiscal 2025 it was $433.81M, up 718.5% from the year before. The highest annual figure on record is $433.81M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $433.81M | +718.5% |
| FY2024 | Sep 30, 2024 | $53.00M | +3.4% |
| FY2023 | Sep 30, 2023 | $51.26M | -20.6% |
| FY2022 | Sep 30, 2022 | $64.53M | -14.4% |
| FY2021 | Sep 30, 2021 | $75.35M | +56.5% |
| FY2020 | Sep 30, 2020 | $48.14M | +36.5% |
| FY2019 | Sep 30, 2019 | $35.27M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $433.81M | +746.3% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $207.39M | +221.4% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $53.00M | -29.7% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $49.85M | +3.6% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $51.26M | +45.3% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $64.53M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $75.35M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $48.14M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $35.27M | – |
See a number that looks wrong?